Posters

Extended macular IOL for cataracts in AMD patients

Poster Details

First Author: J.Hoyos-Chacon SPAIN

Co Author(s):    M. Cigales   J. Hoyos Campillo                 

Abstract Details

Purpose:

To present our preliminary results using iolAMD Eyemax mono in patients with cataract and age-related macular degeneration (AMD)

Setting:

Instituto Oftalmologico Hoyos. Sabadell, Barcelona (Spain) Hospital Esperit Sant. Santa Coloma de Gramanet, Barcelona (Spain)

Methods:

We present 3 patients (4 eyes) with dry AMD and cataract. We selected patients with corrected distance visual acuity (CDVA) better than 20/200 and no complete macular geographic atrophy by checking optical coherence tomography (OCT) and retinography. Standard phacoemulsification cataract surgery was performed and an Eyemax mono IOL was implanted in the capsular bag without complications.

Results:

Patients’ ages were from 73 to 84 years old. PATIENT 1 (monocular): CDVA improved from 20/125 to 20/50 and corrected near visual acuity (CNVA) improved from 20/400 to 20/200. PATIENT 2 (monocular): CDVA improved from 20/60 to 20/30 and CNVA improved from 20/25 to 20/20. PATIENT 3 (binocular): right eye CDVA improved from 20/30 to 20/20 and CNVA improved from 20/25 to 20/20. Left eye CDVA improved from 20/50 to 20/25 and CNVA improved from 20/25 to 20/20. The Early Treatment Diabetic Retinopathy Study (ETDRS) charts improved in our patients from 37 letters to 47 letters after surgery.

Conclusions:

The iolAMD Eyemax mono is an extended macular IOL that delivers an optimized retinal image to all macular areas within 10 degrees of retinal eccentricity. This is a good option in selected patients with AMD and cataracts performing our standard cataract surgery. Further work is required to determine the full potential of extended macular vision technology. A future piggyback Eyemax mono IOL could show the real benefit of this IOL.

Financial Disclosure:

... travel has been funded, fully or partially, by a competing company